Announcements Trials
Browse Landscape

Phase

Phase 1 41Phase 2 26Phase 1/2 9Phase 3 4Phase 4 2Phase EARLY_PHASE1 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 128Thoracic 94Breast 55Genitourinary 49Head & Neck 38Gynecologic 38Lymphoid 26Tumor-Agnostic 4Sarcoma 4Other solid neoplasm 2Classical hematology 1

Conditions

Neoplasms, Unknown Primary 1Neoplasms 1Neoplasm Metastasis 1Carcinoma 1

Interventions

Carboplatin 8Paclitaxel 7Fluorouracil 7Cisplatin 7atezolizumab 5Trastuzumab 5Pemetrexed 5Oxaliplatin 5Leucovorin 5Bevacizumab 5pembrolizumab 4Gemcitabine 4Capecitabine 4Albumin-Bound Paclitaxel 4Surveys and Questionnaires 3Observation 3Leuprolide 3Irinotecan 3Glutamine 3Drug Therapy 3Docetaxel 3Dexamethasone 3130-nm albumin-bound paclitaxel 3trifluridine tipiracil drug combination 2regorafenib 2osimertinib 2enzalutamide 2Surgical Procedures, Operative 2Standard of Care 2Sorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Gemcitabine × Tumor-Agnostic × Clear all
NCT03665441 2022-10-18

Trybeca-1

ERYtech Pharma

Phase 3 Completed
512 enrolled 19 charts
Tumor-Agnostic

Neoplasms

NCT04167007 2020-08-18

GEMFOX

Assistance Publique - Hôpitaux de Paris

Phase 3 Unknown
400 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT00193596 2013-05-03

Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site

SCRI Development Innovations, LLC

Phase 3 Completed
198 enrolled 7 charts
Tumor-Agnostic

Neoplasms, Unknown Primary

NCT00126269 2006-09-08

Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Unknown
192 enrolled
Tumor-Agnostic

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡